Vor Bio is advancing therapies that aim to correct autoimmune disease biology, moving beyond symptom control toward lasting improvement
Vor Bio is advancing therapies that aim to correct autoimmune disease biology, moving beyond symptom control toward lasting improvement. Their lead program, telitacicept, is a first-in-class BAFF/APRIL inhibitor designed to rebalance immunity and deliver consistent clinical benefit.